TY - JOUR T1 - Cost effectiveness of adalimumab for the treatment of ankylosing spondylitis in the United Kingdom. JO - Rheumatology (Oxford) PY - 2007/08/01 AU - Botteman MF AU - Hay JW AU - Luo MP AU - Curry AS AU - Wong RL AU - van Hout BA ED - DO - DOI: 10.1093/rheumatology/kem031 VL - 46 IS - 8 SP - 1320 EP - 1328 Y2 - 2025/05/28 ER -